Femme et Homme
- | Pays :
- Germany
- United Kingdom
- France
- | Organes : -
- | Spécialités : -
Extrait
An open-label, non-randomized, multi-centre, Phase I/II trial to assess the efficacy and safety of 2 schedules of PXD101 in combination with idarubicin in patients with AML not suitable for standard intensive therapy.
Critère d'inclusion
- Acute Myeloid Leukemia